Whole Genome Sequencing (WGS)

The recommended coverage for a WGS test is typically 30x, meaning each base of the genome is read an average of 30 times. This coverage ensures high accuracy and reliability in identifying genetic variants across the entire genome, making the whole genome sequencing test suitable for clinical and diagnostic purposes.

Whole genome sequencing can identify genetic variants associated with increased risk for autoimmune diseases, but it does not diagnose the diseases directly. A whole genome sequencing test uncovers predispositions based on your genetic makeup, supporting early risk assessment and enabling more personalized healthcare planning.

A whole genome sequencing test can detect a wide range of conditions, including inherited genetic disorders, cancer predispositions, rare and undiagnosed diseases, and pharmacogenomic responses. The WGS test provides deep insights into health risks, helping guide early diagnosis, preventive care, and personalized treatment strategies.